| Dr Todd S Perlstein, MD | |
|
6750 E Baywood Ave # 301, Mesa, AZ 85206-1749 | |
| (480) 835-6100 | |
| (480) 461-4243 |
| Full Name | Dr Todd S Perlstein |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 27 Years |
| Location | 6750 E Baywood Ave # 301, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588623912 | NPI | - | NPPES |
| 686956 | Medicaid | AZ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Banner Gateway Medical Center | Gilbert, AZ | Hospital |
| Banner Heart Hospital | Mesa, AZ | Hospital |
| Banner Ironwood Medical Center | Queen creek, AZ | Hospital |
| Banner Goldfield Medical Center | Apache junction, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tri-city Cardiology Consultants Pc | 2062303076 | 40 |
News Archive
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.
In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.
As part of a joint research effort with the University of Michigan, scientists from the Florida campus of The Scripps Research Institute have for the first time defined the structure of one of the cell's most basic engines, which is required for cell growth, as it assembles from its components.
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
Philogen S.p.A. today announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach.
› Verified 2 days ago
| Entity Name | Tri-city Cardiology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144288416 PECOS PAC ID: 2062303076 Enrollment ID: O20040322000116 |
News Archive
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.
In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.
As part of a joint research effort with the University of Michigan, scientists from the Florida campus of The Scripps Research Institute have for the first time defined the structure of one of the cell's most basic engines, which is required for cell growth, as it assembles from its components.
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
Philogen S.p.A. today announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach.
› Verified 2 days ago
| Entity Name | Banner Cancer Center Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518253152 PECOS PAC ID: 6103097779 Enrollment ID: O20110913000224 |
News Archive
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.
In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.
As part of a joint research effort with the University of Michigan, scientists from the Florida campus of The Scripps Research Institute have for the first time defined the structure of one of the cell's most basic engines, which is required for cell growth, as it assembles from its components.
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
Philogen S.p.A. today announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Todd S Perlstein, MD 6402 E Superstition Springs Blvd Ste 224, Mesa, AZ 85206-4394 Ph: (480) 835-6100 | Dr Todd S Perlstein, MD 6750 E Baywood Ave # 301, Mesa, AZ 85206-1749 Ph: (480) 835-6100 |
News Archive
Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide Capsules, 12.5 mg.
In a new medRxiv* preprint study, a team of researchers led by Cécile Viboud of the National Institute of Health analyzed different models predicting the course of the pandemic in the United States for the rest of 2021.
As part of a joint research effort with the University of Michigan, scientists from the Florida campus of The Scripps Research Institute have for the first time defined the structure of one of the cell's most basic engines, which is required for cell growth, as it assembles from its components.
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
Philogen S.p.A. today announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach.
› Verified 2 days ago
Dr. Emmanuel A Bayongan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-543-2034 Fax: 480-512-6089 | |
Dr. Sanjeev Gopal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd, 104-105, Mesa, AZ 85206 Phone: 602-802-8700 Fax: 602-802-8799 | |
Mouhsen H Alhakeem, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Road, Attn Amanda Gump/hospitalist, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Bindu Jayavelu, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 301 S Power Rd Ste 103, Mesa, AZ 85206 Phone: 480-325-7535 Fax: 480-325-7462 | |
Mr. Robert Bobek Arashahi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5652 E Baseline Rd, Mesa, AZ 85206 Phone: 480-477-7166 | |
Mr. Robert P Tully, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7525 E Broadway Rd, Ste 2, Mesa, AZ 85208 Phone: 480-981-9800 Fax: 480-985-9465 | |
Joshua D Cohen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6750 E Baywood Ave, 301, Mesa, AZ 85206 Phone: 480-835-6100 Fax: 480-461-4261 |